COVAX vaccine roll-out

Deliveries of COVID-19 vaccines funded through the Gavi COVAX AMC to lower-income countries has begun.

Last update: 5 March 2021 17:15 CET

COVAX has now shipped over 12 million COVID-19 vaccines to 19 countries in just 10 days.

Learn more

Credit: UNICEF Sudan

Top stories

View all news

Geneva/Oslo/New York, 2 March 2021 – The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi) and the World Health Organization (WHO), as co-leads of the COVAX initiative for equitable global access to COVID-…

Today, the governments of Côte d’Ivoire and Ghana began COVID-19 vaccination campaigns aimed at protecting healthcare workers

COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries to Abidjan, Cote d’Ivoire are expected this week.

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.

Learn more

The COVID-19 vaccine race

Pre-clinical
182vaccines
are being explored in lab experiments and animals
PHASE 1
24 vaccines
are undergoing safety tests in healthy young individuals
Phase 2
28vaccines
are being tested in broader groups of people
Phase 3
21vaccines
are in large international trials to test their impact on COVID-19
APPROVED
11vaccines
are approved and licensed for general use
Phase 4
4vaccines
are being monitored in the wider population after being approved

Source: COVID-19 Vaccine Tracker

Learn more

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

To make the world safe from COVID-19, we need everyone vaccinated, including children. To get back to normality, we also need vaccinated adults, ongoing safety measures, safe re-opening of schools, access to all recommended vaccines – and…

As political and public health leaders across the world work to encourage people to get vaccinated against COVID-19, what can they learn from the King of Rock ‘n’ Roll getting jabbed?

Reaching the goals of the plan requires the best possible interaction between public and private -for profit and not-for-profit - healthcare sectors.

Supported countries

Supported Countries

Our impact

Syringe >822 million children immunised
First aid locator >14 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >150 US$ billion in economic benefits for countries (2000–2017)
Children 85% of the world's children reached by routine immunisation

Our mission: protect people's health

Saving children’s lives and protecting people’s health by increasing equitable use of vaccines in lower-income countries

Learn more

Saving children’s lives and protecting people’s health by increasing equitable use of vaccines in lower-income countries

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Like. Follow. Share.

    Subscribe to our newsletter